Cargando…

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery

BACKGROUND: Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, during RT. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aizawa, Takuya, Maebayashi, Toshiya, Ishibashi, Naoya, Sakaguchi, Masakuni, Sato, Akahiko, Yamaguchi, Kenya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552428/ https://www.ncbi.nlm.nih.gov/pubmed/37794380 http://dx.doi.org/10.1186/s12894-023-01323-5

Ejemplares similares

Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer
por: Maebayashi, Toshiya, et al.
Publicado: (2017)

Reasons for discontinuation of radiation therapy and effective countermeasures
por: Maebayashi, Toshiya, et al.
Publicado: (2018)

Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer
por: Sakaguchi, Masakuni, et al.
Publicado: (2021)

Organizing pneumonia after thoracic radiotherapy followed by anti‐PD‐1 antibody treatment for patients with lung cancer: Three case reports
por: Sakaguchi, Masakuni, et al.
Publicado: (2019)

Docetaxel-induced radiation recall dermatitis with atypical features: A case report
por: Sakaguchi, Masakuni, et al.
Publicado: (2018)

Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor: A case report
por: Sakaguchi, Masakuni, et al.
Publicado: (2015)

Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels
por: Ishibashi, Naoya, et al.
Publicado: (2022)

Is pectus excavatum a risk factor for radiation‐induced lung disease in patients undergoing radiation therapy following breast‐conserving surgery?
por: Ishibashi, Naoya, et al.
Publicado: (2018)

A long-surviving patient with advanced esophageal basaloid squamous cell carcinoma treated only with radiotherapy: case report and literature review
por: Maebayashi, Toshiya, et al.
Publicado: (2017)

Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer
por: Ishibashi, Naoya, et al.
Publicado: (2017)

Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study
por: Sakaguchi, Masakuni, et al.
Publicado: (2016)

Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature
por: Maebayashi, Toshiya, et al.
Publicado: (2015)

Successful Pregnancy and Delivery After Radiation With Ovarian Shielding for Acute Lymphocytic Leukemia Before Menarche
por: Ishibashi, Naoya, et al.
Publicado: (2015)

Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach
por: Vigna‐Taglianti, Riccardo, et al.
Publicado: (2020)

Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Early Detection of Secondary Bladder Urothelial Carcinoma and Disseminated Bone Metastases with Normal Prostate-Specific Antigen Level after Pelvic Salvage Radiotherapy in Prostate Cancer
por: Shin, Teak Jun, et al.
Publicado: (2023)

Are all prostate cancer patients "fit" for salvage radiotherapy?
por: González-San Segundo, Carmen, et al.
Publicado: (2020)

Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy
por: Kosuri, Satyajit, et al.
Publicado: (2012)

Radiation therapy for vaginal cancer in complete uterine prolapse with intrauterine adhesion: a case report
por: Ishibashi, Naoya, et al.
Publicado: (2019)

Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer
por: Montalvo, Steven K., et al.
Publicado: (2022)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
por: Wegener, Daniel, et al.
Publicado: (2022)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
por: Umezawa, Rei, et al.
Publicado: (2011)

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy
por: Gawkowska-Suwinska, Marzena, et al.
Publicado: (2010)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer
por: Şendoğan, Furkan, et al.
Publicado: (2023)

Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer
por: Shiota, Masaki, et al.
Publicado: (2022)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
por: Schmitz, Matthew D, et al.
Publicado: (2010)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
por: Pinkawa, Michael, et al.
Publicado: (2012)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Interim Prostate-Specific Antigen: Predicting for Biochemical Failure During Salvage Radiation Therapy After Prostatectomy
por: Cardoso, Michael, et al.
Publicado: (2021)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
por: Gonzalez-Moya, Ana, et al.
Publicado: (2022)

Prostate specific antigen /
Publicado: (2001)

The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
por: Hjelle, Line V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0c4hac0if3tcmphm3f63o1lno3